Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
🇧🇷 BR Market
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Healthcare
Any
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
Create a narrative
Community
/
Brazil
/
Healthcare
Healthcare Brazilian Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Healthcare Brazilian Investing Ideas
All companies
Popular
Undervalued
Overvalued
Hapvida Participações e Investimentos
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Urban Clinic Expansion And AI Integration Will Transform Brazilian Healthcare
Key Takeaways Expansion of healthcare infrastructure and digital innovations are driving operational efficiency, improved care, and increased market share among Brazil's growing insured population. Integration of acquisitions and process streamlining supports cost control, revenue predictability, and long-term margin growth through organic expansion and risk management.
View narrative
R$59.04
FV
34.3% undervalued
intrinsic discount
8.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
Odontoprev
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Brazil Dental Insurance Expansion Will Harness Exclusive Bradesco Channel
Key Takeaways Expansion into SME and individual markets, aided by exclusive partnerships and growing dental awareness, is driving outperformance and recurring revenue growth. Digital investments and a profitable portfolio shift enhance operational efficiency, boost margins, and reinforce long-term competitive resilience.
View narrative
R$12.56
FV
4.6% overvalued
intrinsic discount
3.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
Updated
narrative
Hapvida Participações e Investimentos
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
Rising Claims And Costly Integrations Will Hinder Brazil's Healthcare Delivery
Key Takeaways Persistent medical inflation, high claims ratios, and integration challenges risk eroding profitability and margins despite efforts in verticalization and network expansion. Economic volatility, growing competition, and increased regulatory pressures threaten revenue growth and customer retention amid shifting consumer sentiment and affordability concerns.
View narrative
R$31.85
FV
21.8% overvalued
intrinsic discount
8.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Hapvida Participações e Investimentos
AN
AnalystHighTarget
Consensus Narrative from 14 Analysts
Telemedicine And AI Will Revolutionize Brazil's Healthcare
Key Takeaways Aggressive integration, innovation in care delivery, and rapid hospital expansion are expected to boost growth, margins, and long-term pricing power beyond current expectations. AI-driven digital health, tailored products, and government partnerships position Hapvida to outpace competitors and consolidate market share as Brazil's healthcare landscape evolves.
View narrative
R$85.44
FV
54.6% undervalued
intrinsic discount
12.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Fleury
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Aging Population And AI Will Redefine Preventive Healthcare
Key Takeaways Integration of acquisitions and advanced technology adoption position Fleury for significant scalability, margin expansion, and superior returns relative to expectations. Premium market presence, digital transformation, and asset-light expansion strategies drive accelerated growth and strengthen long-term market leadership potential.
View narrative
R$19.5
FV
20.4% undervalued
intrinsic discount
7.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Oncoclínicas do Brasil Serviços Médicos
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Brazil's Aging Demographics And Digital Health Will Expand Oncology Care
Key Takeaways Accelerated growth through acquisitions, payer partnerships, and new oncology centers positions Oncoclínicas for market share gains and operational scale. Leadership in precision oncology, digital health, and advanced therapies supports service differentiation, higher margins, and sustained earnings outperformance.
View narrative
R$8.67
FV
67.2% undervalued
intrinsic discount
13.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
8 days ago
author updated this narrative
Oncoclínicas do Brasil Serviços Médicos
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Debt Reduction And Revenue Diversification Will Secure Future Stability
Key Takeaways Strategic partnerships and revenue diversification efforts aim to stabilize and enhance growth, reducing reliance on major clients and expanding market reach. Operational efficiency and conservative financial management are set to optimize margins, strengthen financial health, and bolster investor confidence.
View narrative
R$4.49
FV
36.7% undervalued
intrinsic discount
6.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
13 days ago
author updated this narrative
Rede D'Or São Luiz
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Brazil's Aging Demographics And IT Upgrades Will Expand Hospital Capacity
Key Takeaways Structural trends and portfolio innovations are set to drive sustained demand, diversified revenue streams, and improved profitability for Rede D'Or São Luiz. Technological investment, expanding hospital capacity, and strong cash generation will enhance cost efficiency, margin expansion, and flexibility for further organic and inorganic growth.
View narrative
R$41.98
FV
1.5% undervalued
intrinsic discount
12.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
14 days ago
author updated this narrative
Fleury
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Rising Inequality In Brazil And Digital Disruption Will Compress Margins
Key Takeaways Rising inequality, government cost controls, and increased competition threaten future demand, pricing power, and profitability for Fleury in Brazil's private healthcare sector. Rapid digital disruption and reliance on acquisitions risk eroding Fleury's market differentiation, pressuring margins and hampering long-term integration and earnings growth.
View narrative
R$12.5
FV
24.2% overvalued
intrinsic discount
6.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative